Key result
Intermittent haemodialysis in dogs with Stage IV CKD improved heart rate variability and reduced creatinine, urea, and phosphorus more effectively than clinical treatment, despite arrhythmias.
Why the study?
Cardiovascular monitoring is important to detect cardiovascular repercussions during intermittent haemodialysis for chronic kidney disease, but heart rate variability and electrocardiographic parameters had not been described in dogs with Stage IV CKD.
Does intermittent haemodialysis affect heart rate variability and electrocardiographic parameters in dogs with Stage IV chronic kidney disease?
Does intermittent haemodialysis affect heart rate variability and electrocardiographic parameters in dogs with Stage IV chronic kidney disease?
In dogs with Stage IV CKD, intermittent hemodialysis improves heart rate variability and renal biomarkers compared to fluid therapy, though it is associated with hypokalemia and supraventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
May guide veterinary CKD management; leaves open human translation and arrhythmia effects.
Intermittent haemodialysis (IHD) is used in dogs with chronic kidney disease (CKD) to reduce azotaemia. Monitoring the cardiovascular system plays an important role in this treatment to detect cardiovascular repercussions. Heart rate variability (HRV) and dispersions of the QT interval and P wave are important markers for mortality risk in humans. This study aimed to describe the time-domain and frequency-domain heart rate variability indexes, P and QT dispersions and electrocardiographic alterations observed in dogs with Stage IV CKD undergoing IHD. Thirty dogs of both sexes, of varying ages and breeds, and weighing between 15 and 30 kg were used. Animals were divided into three groups, control (10 healthy dogs), clinical treatment (10 dogs with CKD IV submitted to clinical treatment twice a week) and IHD (10 dogs with CKD IV submitted to clinical treatment and to dialysis treatment with intermittent haemodialysis twice a week). Clinical, laboratory, HRV indexes and electrocardiographic parameters, as well as QT and P-wave dispersions, were assessed in both CKD groups, prior to and after the end of each clinical treatment/IHD session during the first three sessions. Dogs with CKD IV undergoing IHD had clinically important electrolyte imbalances, primarily hypokalaemia, and pertinent electrocardiographic findings, such as the occurrence of supraventricular arrhythmias and increases in possible predictive parameters for arrhythmias. In spite of these observations, HRV indexes were better in animals undergoing haemodialysis and, in addition, IHD was more effective at reducing levels of creatinine, urea and phosphorus compared to intravenous fluid therapy treatment.
No takes yet. Share an insight, caveat, or question.
Alfonso et al. (2020) studied Stage IV Chronic Kidney Disease (n=30). Intermittent haemodialysis vs. Clinical treatment (intravenous fluid therapy) was evaluated on Heart rate variability indexes, P and QT dispersions, and electrocardiographic alterations. Intermittent haemodialysis in dogs with Stage IV CKD improved heart rate variability and reduced creatinine, urea, and phosphorus more effectively than clinical treatment, despite arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: